RWR Insights Mental health disorders remain the highest unmet medical need, surpassing cancer. One in four of us is affected by mental illness. That’s a friend, a partner, a Continue Reading
CONTEXT: Peer reviewed paper reviewing standard treatments for non-infectious uveitis, which is a major cause of vision loss. This data review includes analysis from both RCT and RWR studies to Continue Reading
CONTEXT: Commercial announcement of yet another RWD tie-up. IMPACT: Low READ TIME: 1 min Quality Level Mean [1 – 10]: 2 1. “FAIRFAX, Va., April 7, 2021 /PRNewswire/ Continue Reading
CONTEXT: Latest update (8 April 2021) from LEEM describing the role of the QP PV | Must read! IMPACT: Medium READ TIME: 1 min Quality Level Mean [1 – 10]: Continue Reading
CONTEXT: Yet another announcement of a venture capital funded company focused on commercialising real-world data sources | Are we opening up sources or slamming the door shut unless you have Continue Reading
CONTEXT: Commercial announcement of another in what is becoming the biggest rend this year – access to RWD. I don’t know about you, but I’m intrigued by the phrase “research Continue Reading
CONTEXT: A comprehensive summary of multiple studies | Low key press release with potentially big impact in the real world IMPACT: Medium READ TIME: 3 mins Quality Level Mean [1 Continue Reading
CONTEXT: When the world falls apart, we still (thankfully) have studies focusing on the stuff (viruses) that impact us when we aren’t focusing on COVID | This is a retrospective Continue Reading
CONTEXT: Prospective observational study in releasing remitting multiple sclerosis (RRMS) with a relatively old treatment showing a fairly content and stable patient population in Germany | Study conducted between 2015 Continue Reading
CONTEXT: At first glance this interview article about an app developed to measure a set of performance indicators may seem to be on the fringes of “proper science”. However, patients Continue Reading
